v3.26.1
Segment Information
 12 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Information

Note 14 — Segment Information

The Company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner. The Company manages its business primarily by managing its international network of independent consultants through similar commission plans. Most products available to customers in the United States are available to customers across all markets internationally. These products are purchased through third-party manufacturers by the Company's corporate office in the United States and sold to each international market. Pricing for all products is determined at the Company's corporate office in the United States. Accordingly, for disclosure purposes, the Company has a single reporting segment, which is reported on the Company’s consolidated financial statements.

The Chief Operating Decision Maker (“CODM”) is the Company’s Chief Executive Officer. The CODM regularly reviews consolidated financial information and performance used to make decisions about the Company as a whole and without distinguishing or grouping of operations based on asset type, revenue, geographic location, tenant or other factors.

The CODM evaluates performance through consolidated financial budget-to-actual variances on a monthly and quarterly basis and allocates resources based on net income as reported in the consolidated statements of operations. The measure of segment assets is reported on the balance sheet as total consolidated assets. Total expenditures for long-lived assets are reported on the consolidated statements of cash flows.

The following table presents the Company’s segment revenue and expenses and segment net income for the fiscal years ended June 30, 2026 and 2025 (in thousands):

 

 

Year ended June 30,

 

 

2026

 

 

2025

 

Revenue, net

 

$

182,586

 

 

$

228,530

 

Cost of sales

 

 

(40,973

)

 

 

(44,864

)

Consultant commissions

 

 

(72,957

)

 

 

(95,920

)

Consultant incentives, promotions, and recognition

 

 

(4,137

)

 

 

(6,340

)

Labor and benefits

 

 

(26,958

)

 

 

(31,216

)

Stock compensation

 

 

(2,346

)

 

 

(5,702

)

Events

 

 

(4,065

)

 

 

(3,791

)

Depreciation and amortization

 

 

(2,773

)

 

 

(3,156

)

Credit card and bank processing fees

 

 

(5,187

)

 

 

(6,694

)

Other segment items(1)

 

 

(17,288

)

 

 

(19,035

)

Interest income

 

 

213

 

 

 

466

 

Interest expense

 

 

(49

)

 

 

(35

)

Income tax expense

 

 

(994

)

 

 

(2,438

)

Net income

 

$

5,072

 

 

$

9,805

 

 

(1) Other general and administrative expenses include legal, professional services, rent, utilities, and other miscellaneous expenses.

The following table presents the Company’s long-lived assets for its most significant geographic markets (in thousands):

 

 

June 30, 2026

 

 

June 30, 2025

 

United States

 

$

21,393

 

 

$

18,446

 

Foreign:

 

 

 

 

 

 

Japan

 

 

1,431

 

 

 

1,901

 

Other foreign markets

 

 

280

 

 

 

472

 

Total foreign markets

 

 

1,711

 

 

 

2,373

 

Total long-lived assets

 

$

23,104

 

 

$

20,819

 

 

The Company has identified two major markets with revenues exceeding 10% of consolidated total revenue: the United States and Japan. For the fiscal years ended June 30, 2026 and 2025, there are 17 and 16 other markets, respectively, each of which individually is less than 10% of consolidated total revenue. Sales are recorded in the market in which the transaction occurred. The following table presents the Company’s revenue disaggregated by these markets (in thousands):

 

 

Year ended June 30,

 

 

2026

 

 

2025

 

United States

 

$

135,404

 

 

$

178,442

 

Foreign:

 

 

 

 

 

 

Japan

 

 

24,148

 

 

 

25,394

 

Other foreign markets

 

 

23,034

 

 

 

24,694

 

Total foreign markets

 

 

47,182

 

 

 

50,088

 

Total revenue, net

 

$

182,586

 

 

$

228,530

 

 

Major Products

The Company’s revenue for the fiscal years ended June 30, 2026 and 2025 is largely attributed to three product lines: Protandim®, TrueScience®, and LifeVantage®. On a combined basis, these three product lines represent approximately 83.3% and 87.6% of the Company’s total net revenue for the fiscal years ended June 30, 2026 and 2025, respectively.

The following table shows revenue by product line for the fiscal years ended June 30, 2026 and 2025 (in thousands):

 

 

Year ended June 30,

 

 

2026

 

 

2025

 

Protandim® product line

 

$

81,989

 

 

$

95,328

 

TrueScience® product line

 

 

37,853

 

 

 

48,712

 

LifeVantage® product line

 

 

32,258

 

 

 

61,327

 

AXIO® product line

 

 

15,006

 

 

 

15,312

 

LoveBiome® product line

 

 

9,121

 

 

 

—

 

Petandim® product line

 

 

1,961

 

 

 

2,117

 

Other(1)

 

 

4,398

 

 

 

5,734

 

Total revenue, net

 

$

182,586

 

 

$

228,530

 

 

(1) Other revenue includes shipping and handling revenue, event related revenue, and other revenues impracticable to allocate to a specific product line.

For the fiscal year ended June 30, 2026, the Company phased out the use of PhysIQ™ and placed this product under the LifeVantage® brand. During the fiscal years ended June 30, 2026 and 2025, revenue from PhysIQ™ was $3.8 million and $5.1 million respectively, and now included in the LifeVantage® product line revenue.